Ubs Asset Management Americas Inc Adma Biologics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 816,590 shares of ADMA stock, worth $14.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
816,590
Previous 511,526
59.64%
Holding current value
$14.7 Million
Previous $8.77 Million
84.69%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ADMA
# of Institutions
390Shares Held
190MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$336 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$303 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$232 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$206 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$102 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.54B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...